Press releases

29
Apr 2024
19:05 E.S.T.

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023

Read more
22
Apr 2024
15:16 E.S.T.

Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs

Read more
10
Apr 2024
14:26 E.S.T.

Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs

Read more
8
Apr 2024
09:37 E.S.T.

Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting

Read more
16
Jan 2024
21:30 E.S.T.

Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US